Ningbo David Medical Device Future Growth
Future criteria checks 5/6
Ningbo David Medical Device is forecast to grow earnings and revenue by 49.3% and 40% per annum respectively while EPS is expected to grow by 49.5% per annum.
Key information
49.3%
Earnings growth rate
49.5%
EPS growth rate
Medical Equipment earnings growth | 24.5% |
Revenue growth rate | 40.0% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 23 Aug 2023 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 1,294 | 363 | N/A | 422 | 1 |
12/31/2024 | 971 | 276 | N/A | 178 | 1 |
3/31/2024 | 616 | 136 | 44 | 118 | N/A |
12/31/2023 | 618 | 148 | 95 | 135 | N/A |
9/30/2023 | 615 | 144 | 107 | 156 | N/A |
6/30/2023 | 614 | 154 | 88 | 146 | N/A |
3/31/2023 | 566 | 138 | 85 | 136 | N/A |
1/1/2023 | 506 | 97 | 62 | 112 | N/A |
9/30/2022 | 498 | 89 | 80 | 105 | N/A |
6/30/2022 | 481 | 49 | 109 | 114 | N/A |
3/31/2022 | 477 | 68 | 81 | 87 | N/A |
1/1/2022 | 474 | 80 | 45 | 51 | N/A |
9/30/2021 | 469 | 77 | 76 | 88 | N/A |
6/30/2021 | 482 | 146 | 64 | 87 | N/A |
3/31/2021 | 478 | 144 | 87 | 110 | N/A |
12/31/2020 | 460 | 136 | 114 | 138 | N/A |
9/30/2020 | 436 | 148 | 82 | 102 | N/A |
6/30/2020 | 398 | 99 | 95 | 104 | N/A |
3/31/2020 | 366 | 67 | 84 | 93 | N/A |
12/31/2019 | 356 | 62 | 79 | 89 | N/A |
9/30/2019 | 341 | 32 | 71 | 81 | N/A |
6/30/2019 | 310 | 23 | 53 | 64 | N/A |
3/31/2019 | 300 | 24 | 57 | 69 | N/A |
12/31/2018 | 300 | 29 | 55 | 70 | N/A |
9/30/2018 | 287 | 34 | 27 | 43 | N/A |
6/30/2018 | 290 | 34 | 26 | 44 | N/A |
3/31/2018 | 295 | 42 | 17 | 42 | N/A |
12/31/2017 | 304 | 47 | N/A | 56 | N/A |
9/30/2017 | 303 | 65 | N/A | 70 | N/A |
6/30/2017 | 296 | 69 | N/A | 69 | N/A |
3/31/2017 | 279 | 64 | N/A | 72 | N/A |
12/31/2016 | 265 | 62 | N/A | 77 | N/A |
9/30/2016 | 237 | 57 | N/A | 64 | N/A |
6/30/2016 | 222 | 49 | N/A | 51 | N/A |
3/31/2016 | 221 | 46 | N/A | 44 | N/A |
12/31/2015 | 219 | 45 | N/A | 48 | N/A |
9/30/2015 | 225 | 53 | N/A | 50 | N/A |
6/30/2015 | 223 | 53 | N/A | 56 | N/A |
3/31/2015 | 230 | 55 | N/A | 74 | N/A |
12/31/2014 | 227 | 54 | N/A | 68 | N/A |
9/30/2014 | 227 | 54 | N/A | 63 | N/A |
6/30/2014 | 218 | 55 | N/A | 63 | N/A |
3/31/2014 | 209 | 57 | N/A | 48 | N/A |
12/31/2013 | 217 | 64 | N/A | 56 | N/A |
9/30/2013 | 230 | 67 | N/A | 63 | N/A |
6/30/2013 | 249 | 76 | N/A | 77 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300314's forecast earnings growth (49.3% per year) is above the savings rate (2.9%).
Earnings vs Market: 300314's earnings (49.3% per year) are forecast to grow faster than the CN market (24.4% per year).
High Growth Earnings: 300314's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300314's revenue (40% per year) is forecast to grow faster than the CN market (14.7% per year).
High Growth Revenue: 300314's revenue (40% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 300314's Return on Equity is forecast to be high in 3 years time